By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement.
Cookie Disclaimer
We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the app and the website, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalized content. You are free to decide in the Cookie Settings which categories you would like to permit. Please note that depending on what you select, the full functionality of the website may no longer be available. You may review and change your choices at any time. Further information can be found in our Privacy Statement.
Cookie Disclaimer
These cookies are necessary for the website to operate. Our website cannot function without these cookies and they can only be disabled by changing your browser preferences.
These cookies enable the provision of advanced functionalities and are used for personalization. The cookies are set in particular in response to your actions and depend on your specific service requests (e.g., setting the language).
These cookies may be set to learn more about your interests and show you relevant ads on other websites. These cookies work by uniquely identifying your browser and device. By integrating these cookies, we aim to learn more about your interests and your surfing behavior and to be able to place our advertising in a targeted manner.
{"analytics":"targeting","share":"targeting"}
Disclaimer
Publication of Merck KGaA, Darmstadt, Germany.
In the United States and Canada the subsidiaries of
Merck KGaA, Darmstadt, Germany operate under the umbrella brand EMD.
Jim is responsible for diagnostics-related programs and activities for the Global Health Institute.
Jim has a proven track record in Global Health with the development and commercialization of the current MUSE Auto CD4/CD4% system, a laboratory instrument designed to monitor T cells in adult and pediatric patients suffering from HIV/AIDS, malaria, and COVID 19 in developing countries.
Jim has more than 30 years of experience in the pharmaceutical/ diagnostic/ biotechnology industry, including 10 years in Life Science. He has efficiently led sales and marketing organizations at Abbott Diagnostics and Horiba Medical. Before joining Merck KGaA, Darmstadt, Germany, Jim has conducted management in three start-up organizations and has taken these companies from incubation to profit. He has an extensive network with the United Nations and other non-government organizations in the field of Global Health.
Jim holds a BS in Psychology from the University of Houston and attended the Graduate School of Management at the University of Dallas.
